Screening of Coexistence Between Sickle Cell Anaemia and G6PD Deficiency

计划入组 100 人 · 首次发布于 2024 年 9 月 26 日

Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia

计划入组 723 人 · 首次发布于 2021 年 4 月 14 日

Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community

计划入组 217 人 · 首次发布于 2022 年 6 月 27 日

Sickle cell disease(Orna)

sickle cell disease therapeutics

Sickle cell disease(GluBio)

David Van Sickle

United States

Gamida Cell

Israel

GAMIDA CELL INC.

United States

Zydus and ICMR Partner to Initiate Phase 2 Trial of Desidustat for Sickle Cell Disease

Overview of Advanced Therapy Medicinal Products (ATMPs) in the European Union

NHS England Approves First CRISPR Gene-Editing Therapy for Beta Thalassaemia Treatment